KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $130,000 | -9.1% | 38,137 | 0.0% | 0.00% | – |
| Q2 2018 | $143,000 | -8.3% | 38,137 | 0.0% | 0.00% | – |
| Q1 2018 | $156,000 | -11.9% | 38,137 | 0.0% | 0.00% | – |
| Q4 2017 | $177,000 | -34.7% | 38,137 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $271,000 | -1.8% | 38,137 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $276,000 | +47.6% | 38,137 | +25.9% | 0.00% | – |
| Q1 2017 | $187,000 | +5.1% | 30,303 | 0.0% | 0.00% | – |
| Q4 2016 | $178,000 | -14.4% | 30,303 | -22.8% | 0.00% | – |
| Q3 2016 | $208,000 | -24.9% | 39,234 | -6.1% | 0.00% | -100.0% |
| Q2 2016 | $277,000 | +42.1% | 41,799 | 0.0% | 0.00% | – |
| Q1 2016 | $195,000 | -7.6% | 41,799 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $211,000 | +43.5% | 41,799 | 0.0% | 0.00% | – |
| Q3 2015 | $147,000 | -73.1% | 41,799 | -23.6% | 0.00% | -100.0% |
| Q2 2015 | $546,000 | -21.6% | 54,700 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $696,000 | -10.1% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $774,000 | +2.9% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $752,000 | -10.6% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $841,000 | -9.8% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $932,000 | +31.6% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $708,000 | +28.3% | 54,700 | 0.0% | 0.00% | +100.0% |
| Q3 2013 | $552,000 | +35.0% | 54,700 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $409,000 | – | 54,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |